Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report
- Collection:
-
Health Policy and Services Research
- Contributor(s):
-
Institute for Clinical and Economic Review, issuing body.
California Technology Assessment Forum, issuing body.
- Publication:
-
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 25, 2018
- Language(s):
-
English
- Format:
-
Text
- Subject(s):
-
Angioedemas, Hereditary -- drug therapy
Angioedemas, Hereditary -- prevention & control
Antibodies, Monoclonal, Humanized -- therapeutic use
Complement C1 Inhibitor Protein -- therapeutic use
Kallikreins -- antagonists & inhibitors
Antibodies, Monoclonal, Humanized -- adverse effects
Antibodies, Monoclonal, Humanized -- economics
Complement C1 Inhibitor Protein -- adverse effects
Complement C1 Inhibitor Protein -- economics
Cost-Benefit Analysis
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Genre(s):
-
Technical Report
- Copyright:
-
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
-
1 online resource (1 PDF file (various pagings))
- Illustrations:
-
Illustrations
- NLM Unique ID:
-
101745056 (See catalog record)
- Permanent Link:
-
http://resource.nlm.nih.gov/101745056
